-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 J8PfrAtjiiulOdoKKW0mNeIHxykRMXJB/gVZL2MBRQ2JvQ0JtfUzUu/Wo9uFvkr7
 Czg714KMssqEAb9fQYRISQ==

<SEC-DOCUMENT>0000012208-07-000002.txt : 20070104
<SEC-HEADER>0000012208-07-000002.hdr.sgml : 20070104
<ACCEPTANCE-DATETIME>20070104163932
ACCESSION NUMBER:		0000012208-07-000002
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20070103
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
FILED AS OF DATE:		20070104
DATE AS OF CHANGE:		20070104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO RAD LABORATORIES INC
		CENTRAL INDEX KEY:			0000012208
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				941381833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07928
		FILM NUMBER:		07510031

	BUSINESS ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DR
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547
		BUSINESS PHONE:		5107247000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k010407.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>8-K re Padou</TITLE>
<META NAME="author" CONTENT="elee">
<META NAME="date" CONTENT="01/04/2007">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:442.8pt"><P style="margin:0pt"><BR>
<BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR><TD width=147.6></TD><TD width=147.6></TD><TD width=147.6></TD></TR>
<TR><TD valign=top width=590.4 colspan=3><P style="line-height:14pt; margin:0pt; font-size:12pt" align=center><B>_______________________________________________________________________</B></P>
<P style="margin:0pt" align=center><BR></P>
<P style="line-height:14pt; margin:0pt; font-size:12pt" align=center><B>UNITED STATES</B></P>
<P style="line-height:16pt; margin:0pt; font-size:14pt" align=center><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="line-height:14pt; margin:0pt; font-size:12pt" align=center><B>Washington, D.C. &nbsp;20549</B></P>
<P style="margin:0pt" align=center><BR></P>
<P style="line-height:18pt; margin:0pt; font-size:16pt" align=center><B>FORM 8-K</B></P>
<P style="margin:0pt" align=center><BR></P>
<P style="line-height:14pt; margin:0pt; font-size:12pt" align=center><B>_______________________________________________________________________</B></P>
<P style="margin:0pt" align=center><BR></P>
<P style="line-height:16pt; margin:0pt; font-size:14pt" align=center><B>CURRENT REPORT</B></P>
<P style="line-height:13pt; margin:0pt; font-size:11pt" align=center><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P style="margin:0pt" align=center><BR></P>
<P style="line-height:14pt; margin:0pt; font-size:12pt" align=center><B>Date of Report: &nbsp;January 3, 2007</B></P>
<P style="line-height:10pt; margin:0pt; font-size:8pt" align=center><B>(Date of earliest event reported)</B></P>
<P style="line-height:10pt; margin:0pt; font-size:8pt" align=center>__________________________________________________________________________________________________________</P>
<P style="margin:0pt" align=center><BR></P>
<P style="line-height:16pt; margin:0pt; font-size:14pt" align=center><B>BIO-RAD LABORATORIES, INC.</B></P>
<P style="margin:0pt" align=center><B>(exact name of registrant as specified in its charter)</B></P>
<P style="margin:0pt" align=center><BR></P>
<P style="line-height:10pt; margin:0pt; font-size:8pt" align=center>__________________________________________________________________________________________________________</P>
<P style="line-height:14pt; margin:0pt; font-size:12pt" align=center>&nbsp;</P>
<P style="line-height:normal; margin:0pt; font-size:12pt" align=center><B>Commission File Number: &nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1-7928&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></B></P>
</TD></TR>
<TR><TD valign=top width=196.8><P style="margin:0pt" align=center><BR></P>
<P style="line-height:13pt; margin:0pt; font-size:11pt" align=center><B><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></B></P>
<P style="line-height:11pt; margin:0pt; font-size:9pt" align=center>(State or other jurisdiction of incorporation or organization)</P>
</TD><TD valign=top width=196.8><P style="margin:0pt" align=center><BR></P>
</TD><TD valign=top width=196.8><P style="margin:0pt" align=center><BR></P>
<P style="line-height:13pt; margin:0pt; font-size:11pt" align=center><B><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;94-1381833&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></B></P>
<P style="line-height:11pt; margin:0pt; font-size:9pt" align=center>(I.R.S. Employer Identification No.)</P>
</TD></TR>
<TR><TD valign=top width=590.4 colspan=3><P style="margin:0pt" align=center><BR></P>
<P style="margin:0pt"><BR></P>
<P style="line-height:14pt; margin:0pt; font-size:12pt" align=center><B>1000 Alfred Nobel Dr.</B></P>
<P style="line-height:14pt; margin:0pt; font-size:12pt" align=center><B>Hercules, California 94547</B></P>
<P style="line-height:11pt; margin:0pt; font-size:9pt" align=center>(Address of Principal executive offices, including zip code)</P>
<P style="margin:0pt" align=center><BR></P>
<P style="line-height:13pt; margin:0pt; font-size:11pt" align=center><B><U>(510) 724-7000</U></B></P>
<P style="line-height:11pt; margin:0pt; font-size:9pt" align=center>(Registrant&#146;s telephone number, including area code)</P>
</TD></TR>
</TABLE>
<P style="margin-top:5pt; margin-bottom:5pt">______________________________________________________________________________________</P>
<P style="margin-top:5pt; margin-bottom:5pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provision:</P>
<P style="margin-top:0pt; margin-bottom:5.9pt">[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
<P style="margin-top:0pt; margin-bottom:5.8pt">[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
<P style="margin-top:0pt; margin-bottom:5.8pt">[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
<P style="margin-top:0pt; margin-bottom:1.7pt">[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
<P style="margin:0pt"><BR>
<BR></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
</DIV><DIV style="width:468pt"><P style="margin-top:5pt; margin-bottom:-12pt; font-family:Times New Roman Bold; page-break-before:always"><FONT FACE="Times New Roman Bold"><B>ITEM 3.01</B></FONT></P>
<P style="margin-top:0pt; margin-bottom:5pt; text-indent:72pt; font-family:Times New Roman Bold"><B>NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD; TRANSFER OF LISTING.</B></P>
<P style="margin-top:0pt; margin-bottom:5pt"><BR></P>
<P style="margin-top:4.15pt; margin-bottom:4.15pt; text-indent:36pt"><FONT FACE="Times New Roman">On December 31, 2006, Mr. Philip L. Padou, a longtime member of the Board of Directors and Chairman of the Audit Committee of Bio-Rad Laboratories, Inc. (the &#147;Company&#148;), unexpectedly passed away. &nbsp;Mr. Padou was 72.</FONT></P>
<P style="margin-top:4.15pt; margin-bottom:4.15pt; text-indent:36pt">On January 3, 2007, the Company voluntarily contacted and informed the staff of the American Stock Exchange (&#147;Amex&#148;) that it believed it was not in material compliance with Section 121(B)(2)(a) of the American Stock Exchange Company Guide because the death of Mr. Padou left the Company with only two independent directors serving on its Audit Committee rather than the requisite three independent directors. &nbsp;The Company is currently seeking a replacement for Mr. Padou to serve on its Board of Directors and Audit Committee in order to regain compliance with the Amex requirements. </P>
<P style="margin-top:4.15pt; margin-bottom:4.15pt; text-indent:36pt">Mr. Ruediger Naumann-Etienne, who has served on the Company&#146;s Board of Directors and Audit Committee since 2001, will be appointed by the Board of Directors to serve as interim Chairman of the Audit Committee.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<P style="line-height:14pt; margin-top:0pt; margin-bottom:12pt; font-size:12pt" align=center><B>SIGNATURES</B></P>
<P style="margin-top:0pt; margin-bottom:12pt"><BR></P>
<P style="margin:0pt; text-indent:36pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt; text-indent:252pt">BIO-RAD LABORATORIES, INC.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<P style="margin-top:0pt; margin-bottom:-12pt">Date<U>: &nbsp;January 4, 2007</U></P>
<P style="margin:0pt; text-indent:252pt">By<U>: /s/ Christine A. Tsingos</U></P>
<P style="margin:0pt; text-indent:270pt">Christine A. Tsingos</P>
<P style="margin:0pt; padding-left:270pt">Vice President and Chief Financial Officer</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=center><BR></P>
<P style="margin:0pt" align=center><BR>
<BR></P>
</DIV><DIV style="width:442.8pt"><P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
</DIV></BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
